A short industry brief on how CGT manufacturers can replace paper-based processes with scalable digital workflows—improving chain-of-identity tracking, accelerating batch release, and reducing delays that can impact patient treatment windows. Download the brief to see the roadmap.

Download this free infographic to see how life sciences teams can use privacy-first, HIPAA-compliant real-world data to build precise HCP and patient audiences, optimize campaigns in flight, and measure real outcomes—not just clicks.

Modern healthcare innovation goes beyond connecting systems—it requires an ecosystem approach that enables proactive, coordinated, and patient-focused engagement. This whitepaper explores how data, AI, and collaboration transform care delivery and outcomes. Download the free whitepaper to learn more.

High performance cell culture media provide an essential environment to ensure cells are producing high titers and high quality biotherapeutics. These attributes are important drivers in determining whether a biotherapeutic can be manufactured commercially with economics that support market launch.

J.Media™ is a new CHO perfusion medium designed to deliver both high productivity and consistent product quality—from development to manufacturing scale.

Key Highlights:

• Robust scalability from 3 L bench scale to 500 L single use bioreactors (SUB)
• Chemically-defined (CD) and animal origin free (AOF)
• Available as liquid for pilot scale and powder for large scale manufacturing.
• Both liquid and powder media can be stored at room temperature
• Powder is stable up to 24 months at room temperature

Generative AI has the potential to transform R&D, but many pharma companies are missing the mark. This paper describes a new model for getting most from AI in R&D.

Download the white paper to learn how advanced purification technologies are redefining efficiency and precision in gene therapy manufacturing.

Download this free white paper to unlock expert insights and strategic guidance designed to help biopharma partners navigate the rapidly evolving ADC therapeutic landscape.